Viewing Study NCT01558167


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-02-20 @ 6:42 PM
Study NCT ID: NCT01558167
Status: COMPLETED
Last Update Posted: 2018-05-15
First Post: 2011-05-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Safety and Efficacy Trial of a Combination of Bendamustine, Rituximab and Lenalidomide in Patients With Chronic Lymphocytic Leukemia
Sponsor: German CLL Study Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module